IL-37 suppresses the sustained hepatic IFN-γ/TNF-α production and T cell-dependent liver injury
- 1 April 2019
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 69, 184-193
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81600448, 81472704)
This publication has 35 references indexed in Scilit:
- In Vivo Expression of Interleukin-37 Reduces Local and Systemic Inflammation in Concanavalin A-Induced HepatitisThe Scientific World Journal, 2011
- IL-37 is a fundamental inhibitor of innate immunityNature Immunology, 2010
- IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infectionProceedings of the National Academy of Sciences, 2010
- IFN‐γ withdrawal after immunotherapy potentiates B16 melanoma invasion and metastasis by intensifying tumor integrin αvβ3 signalingInternational Journal of Cancer, 2008
- Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infectionJournal of Experimental Medicine, 2008
- Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD‐HepII polypeptide of fibronectinInternational Journal of Cancer, 2007
- IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A–induced liver injury in miceHepatology, 2007
- The combined effect of IL-4 and IL-10 suppresses the generation of, but does not change the polarity of, type-1 T cells in Histoplasma infectionInternational Immunology, 2004
- Importance of Kupffer Cells for T-Cell-Dependent Liver Injury in MiceThe American Journal of Pathology, 2000
- Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 CellsJournal of Experimental Medicine, 1997